A short artificial antimicrobial peptide shows potential to prevent or treat bone infections

Abstract Infection of bone is a severe complication due to the variety of bacteria causing it, their resistance against classical antibiotics, the formation of a biofilm and the difficulty to eradicate it. Antimicrobial peptides (AMPs) are naturally occurring peptides and promising candidates for tr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: N. Bormann, A. Koliszak, S. Kasper, L. Schoen, K. Hilpert, R. Volkmer, J. Kikhney, B. Wildemann
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8cc49451c0b64c579e355aeb8941cf1a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8cc49451c0b64c579e355aeb8941cf1a
record_format dspace
spelling oai:doaj.org-article:8cc49451c0b64c579e355aeb8941cf1a2021-12-02T15:06:21ZA short artificial antimicrobial peptide shows potential to prevent or treat bone infections10.1038/s41598-017-01698-02045-2322https://doaj.org/article/8cc49451c0b64c579e355aeb8941cf1a2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01698-0https://doaj.org/toc/2045-2322Abstract Infection of bone is a severe complication due to the variety of bacteria causing it, their resistance against classical antibiotics, the formation of a biofilm and the difficulty to eradicate it. Antimicrobial peptides (AMPs) are naturally occurring peptides and promising candidates for treatment of joint infections. This study aimed to analyze the effect of short artificial peptides derived from an optimized library regarding (1) antimicrobial effect on different bacterial species, (2) efficacy on biofilms, and (3) effect on osteoblast‑like cells. Culturing the AMP-modifications with Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus (including clinical isolates of MRSA and MSSA) and Staphylococcus epidermidis identified one candidate that was most effective against all bacteria. This AMP was also able to reduce biofilm as demonstrated by FISH and microcalorimetry. Osteoblast viability and differentiation were not negatively affected by the AMP. A cation concentration comparable to that physiologically occurring in blood had almost no negative effect on AMP activity and even with 10% serum bacterial growth was inhibited. Bacteria internalized into osteoblasts were reduced by the AMP. Taken together the results demonstrate a high antimicrobial activity of the AMP even against bacteria incorporated in a biofilm or internalized into cells without harming human osteoblasts.N. BormannA. KoliszakS. KasperL. SchoenK. HilpertR. VolkmerJ. KikhneyB. WildemannNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
N. Bormann
A. Koliszak
S. Kasper
L. Schoen
K. Hilpert
R. Volkmer
J. Kikhney
B. Wildemann
A short artificial antimicrobial peptide shows potential to prevent or treat bone infections
description Abstract Infection of bone is a severe complication due to the variety of bacteria causing it, their resistance against classical antibiotics, the formation of a biofilm and the difficulty to eradicate it. Antimicrobial peptides (AMPs) are naturally occurring peptides and promising candidates for treatment of joint infections. This study aimed to analyze the effect of short artificial peptides derived from an optimized library regarding (1) antimicrobial effect on different bacterial species, (2) efficacy on biofilms, and (3) effect on osteoblast‑like cells. Culturing the AMP-modifications with Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus (including clinical isolates of MRSA and MSSA) and Staphylococcus epidermidis identified one candidate that was most effective against all bacteria. This AMP was also able to reduce biofilm as demonstrated by FISH and microcalorimetry. Osteoblast viability and differentiation were not negatively affected by the AMP. A cation concentration comparable to that physiologically occurring in blood had almost no negative effect on AMP activity and even with 10% serum bacterial growth was inhibited. Bacteria internalized into osteoblasts were reduced by the AMP. Taken together the results demonstrate a high antimicrobial activity of the AMP even against bacteria incorporated in a biofilm or internalized into cells without harming human osteoblasts.
format article
author N. Bormann
A. Koliszak
S. Kasper
L. Schoen
K. Hilpert
R. Volkmer
J. Kikhney
B. Wildemann
author_facet N. Bormann
A. Koliszak
S. Kasper
L. Schoen
K. Hilpert
R. Volkmer
J. Kikhney
B. Wildemann
author_sort N. Bormann
title A short artificial antimicrobial peptide shows potential to prevent or treat bone infections
title_short A short artificial antimicrobial peptide shows potential to prevent or treat bone infections
title_full A short artificial antimicrobial peptide shows potential to prevent or treat bone infections
title_fullStr A short artificial antimicrobial peptide shows potential to prevent or treat bone infections
title_full_unstemmed A short artificial antimicrobial peptide shows potential to prevent or treat bone infections
title_sort short artificial antimicrobial peptide shows potential to prevent or treat bone infections
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/8cc49451c0b64c579e355aeb8941cf1a
work_keys_str_mv AT nbormann ashortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT akoliszak ashortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT skasper ashortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT lschoen ashortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT khilpert ashortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT rvolkmer ashortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT jkikhney ashortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT bwildemann ashortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT nbormann shortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT akoliszak shortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT skasper shortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT lschoen shortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT khilpert shortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT rvolkmer shortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT jkikhney shortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
AT bwildemann shortartificialantimicrobialpeptideshowspotentialtopreventortreatboneinfections
_version_ 1718388527946792960